Additionally, therapies such as imatinib, shown to be highly effective at attenuating plexiform neurofibroma growth in mouse models of NF1 (Yang et al., 2008), have exhibited far less efficacy for treating human NF1-associated plexiform neurofibromas (Robertson et al., 2012). The gene discussed is NF1; the disease is plexiform neurofibroma.